Interações medicamentosas
Brexucabtagene autoleucel + Carboplatin
Gravidade: Grave
Brexucabtagene autoleucel and Carboplatin: major interaction.
Última atualização
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Resumo
Carboplatin may reduce the expansion and persistence of CAR T cells through lymphotoxic and myelosuppressive effects. It also adds to infection risk after cell therapy.
O que esta interação significa em palavras simples
Brexucabtagene autoleucel and Carboplatin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Brexucabtagene autoleucel belongs to Oncology; Carboplatin belongs to Oncology.
Por que acontece
Additive immunosuppressive and myelosuppressive effects that may impair CAR T-cell function.
O que fazer
Avoid non-lymphodepleting chemotherapy around leukapheresis and infusion. Monitor blood counts and for infection if chemotherapy is required.
O que perguntar ao farmacêutico
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Brexucabtagene autoleucel e Carboplatin, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Experimente o Pro+ grátis por 14 dias na web. Sem cartão.
Outras interações de Carboplatin
Outras interações de Brexucabtagene autoleucel
Perguntas frequentes
Can I take Brexucabtagene autoleucel with Carboplatin?
MediHelp rates the interaction as major. Brexucabtagene autoleucel and Carboplatin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Carboplatin may reduce the expansion and persistence of CAR T cells through lymphotoxic and myelosuppressive effects. It also adds to infection risk after cell therapy.
How serious is the interaction between Brexucabtagene autoleucel and Carboplatin?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid non-lymphodepleting chemotherapy around leukapheresis and infusion. Monitor blood counts and for infection if chemotherapy is required.
What other medicines interact with Carboplatin?
MediHelp also lists interactions of Carboplatin with, for example, Adenovirus types 4 and 7 live, Amikacin, Amphotericin b deoxycholate. The full list is on the Carboplatin page.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
